These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 12600286

  • 1. [Effects of mitogen-activated protein kinase(MAPK) in cell signal transduction of chronic myelogenous leukemia cell line K562].
    Shang ZC, Sun BZ, Chen ZN, Wang W, Feng Q, Wang S, Zhang T.
    Ai Zheng; 2003 Feb; 22(2):140-2. PubMed ID: 12600286
    [Abstract] [Full Text] [Related]

  • 2. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M.
    J Cell Physiol; 2004 Mar; 198(3):370-6. PubMed ID: 14755542
    [Abstract] [Full Text] [Related]

  • 3. [Inhibitory effects of antisense oligonucleotides targeting mitogen-activated protein kinase (MAPK) mRNA on neonatal rat cardiac fibroblast proliferation induced by Ang II and EGF].
    Ding B, Huang SL, Li YX.
    Sheng Li Xue Bao; 1999 Aug; 51(4):397-406. PubMed ID: 11498967
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ, Ding B, Guo ZG, Li YX.
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [Abstract] [Full Text] [Related]

  • 5. JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation.
    Merkerova M, Bruchova H, Brdicka R.
    Neoplasma; 2007 Jan; 54(6):503-10. PubMed ID: 17949234
    [Abstract] [Full Text] [Related]

  • 6. Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/SR.
    Ohmine K, Nagai T, Tarumoto T, Miyoshi T, Muroi K, Mano H, Komatsu N, Takaku F, Ozawa K.
    Stem Cells; 2003 Jan; 21(3):315-21. PubMed ID: 12743326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
    Moosavi MA, Yazdanparast R, Lotfi A.
    Int J Biochem Cell Biol; 2007 Jan; 39(9):1685-97. PubMed ID: 17543571
    [Abstract] [Full Text] [Related]

  • 9. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek I, Sliwinski T, Poplawski T, Pytel D, Kowalski M, Slupianek A, Skorski T, Blasiak J.
    Mutat Res; 2006 Jan 31; 603(1):74-82. PubMed ID: 16388976
    [Abstract] [Full Text] [Related]

  • 10. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 11. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM, Liu JC.
    J Cell Physiol; 2009 Mar 01; 218(3):568-74. PubMed ID: 19006173
    [Abstract] [Full Text] [Related]

  • 12. [Effects of anti-ABL tyrosine kinase intrabody on the growth of K562 cells in nude mice].
    Xu D, Song JM, Hu Y, Guo H, Cao DJ, Wang P, Liu H, Zhao CH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb 01; 24(1):11-4. PubMed ID: 12905832
    [Abstract] [Full Text] [Related]

  • 13. [Significance of phosphorylation of mitogen-activated protein kinase and signal transducer and activator of transcription 3 and cyclin D1 protein expression in Hodgkin's lymphomas].
    Luo HY, Wang HC, Li YN, Zheng H.
    Ai Zheng; 2003 Mar 01; 22(3):266-9. PubMed ID: 12654183
    [Abstract] [Full Text] [Related]

  • 14. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
    La Rosée P, Jia T, Demehri S, Härtel N, de Vries P, Bonham L, Hollenback D, Singer JW, Melo JV, Druker BJ, Deininger MW.
    Clin Cancer Res; 2006 Nov 01; 12(21):6540-6. PubMed ID: 17085669
    [Abstract] [Full Text] [Related]

  • 15. [Effect of PD98059 on Ras-MAPK signal transduction pathway of chronic myelogenous leukemia].
    Shang ZC, Sun BZ, Chen ZN, Wang J, Feng Q, Wang W, Wang S, Zhang T.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan 01; 19(1):54-5. PubMed ID: 15132907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T.
    Oncogene; 2008 Aug 07; 27(34):4678-89. PubMed ID: 18427551
    [Abstract] [Full Text] [Related]

  • 20. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
    Cao C, Li SR, Dai X, Chen YQ, Feng Z, Qin X, Zhao Y, Wu J.
    Zhonghua Shao Shang Za Zhi; 2008 Apr 07; 24(2):118-21. PubMed ID: 18785412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.